Insight

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Collage photo of Marco Ruella and Ruchi Patel

Jul 21, 2024, 21:50

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Marco Ruella, Assistant Professor Of Medicine and Scientific Director Lymphoma Program at the University of Pennsylvania, shared a post on X about a recent paper by Ruchi Patel et al. published in Science Immunology, commenting:

“Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models.”

“CD5 deletion enhances the antitumor activity of adoptive T cell therapies”

Authors: Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang, Patrizia Porazzi, Marco Ruella et al.

Source: Marco Ruella/X

Aasha Gupta cancer CART immunotherapy Guido Ghilardi liquid cancer models Marco Ruella Nicholas Siciliano Olga Shestova OncoDaily Oncology Ositadimma Ugwuanyi Patrizia Porazzi Puneeth Guruprasad Raymone Pajarillo Ruchi Patel Science Immunology solid cancer models University of Pennsylvania Yi-Hao Chiang Yong Gu Lee Yunlin Zhang

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Special Coverage